Literature DB >> 16932916

Cell-line and tissue-specific signatures of androgen receptor-coregulator transcription.

Jan-Hendrik Bebermeier1, James D Brooks, Samuel E DePrimo, Ralf Werner, Uta Deppe, Janos Demeter, Olaf Hiort, Paul-Martin Holterhus.   

Abstract

Normal genital skin fibroblasts (GSF) and the human prostate carcinoma cell line LNCaP have been used widely as cell culture models of genital origin to study androgen receptor (AR) signaling. We demonstrate that LNCaP shows a reproducible response to androgens as assessed using cDNA-microarrays representing approximately 32,000 unique human genes, whereas several independent GSF strains are virtually unresponsive. We show that LNCaP cells express markedly higher AR protein levels likely contributing to the observed differences of androgen responsiveness. However, previous data suggested that AR-expression levels alone do not determine androgen responsiveness of human GSF compared to LNCaP. We hypothesized that cell-specific differences in expression levels of AR coregulators might contribute to differences in androgen responsiveness and might be found by comparing LNCaP and GSFs. Using the Canadian McGill-database of AR coregulators ( http://www.mcgill.ca/androgendb ), we identified 61 AR-coregulator genes represented by 282 transcripts on our microarray platform that was used to measure transcript profiles of LNCaP and GSF cells. Baseline expression levels of 48 AR-coregulator transcripts representing 33 distinct genes showed significant differences between GSF and LNCaP, four of which we confirmed by reverse transcriptase polymerase chain reaction. Compared to LNCaP, GSFs displayed significant upregulation of AR coregulators that can function as repressors of AR-transactivation, such as caveolin 1. Analysis of a recently published comprehensive dataset of 115 microarrays representing 35 different human tissues revealed tissue-specific signatures of AR coregulators that segregated with ontogenetically related groups of tissues (e.g., lymphatic system and genital tissues, brain). Our data demonstrate the existence of cell-line and tissue-specific expression patterns of molecules with documented AR coregulatory functions. Therefore, differential expression patterns of AR coregulators could modify tissue-specificity and diversity of androgen actions in development, physiology, and disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16932916     DOI: 10.1007/s00109-006-0081-1

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  51 in total

1.  Correlation between genotype, phenotype and sex of rearing in 111 patients with partial androgen insensitivity syndrome.

Authors:  A Deeb; C Mason; Y S Lee; I A Hughes
Journal:  Clin Endocrinol (Oxf)       Date:  2005-07       Impact factor: 3.478

Review 2.  The steroid receptor superfamily: mechanisms of diversity.

Authors:  P J Fuller
Journal:  FASEB J       Date:  1991-12       Impact factor: 5.191

3.  Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells.

Authors:  Takehiko Segawa; Martin E Nau; Linda L Xu; Rao N Chilukuri; Mazen Makarem; Wei Zhang; Gyorgy Petrovics; Isabell A Sesterhenn; David G McLeod; Judd W Moul; Maryanne Vahey; Shiv Srivastava
Journal:  Oncogene       Date:  2002-12-12       Impact factor: 9.867

4.  Assessment of androgen receptor function in genital skin fibroblasts using a recombinant adenovirus to deliver an androgen-responsive reporter gene.

Authors:  M J McPhaul; H U Schweikert; D R Allman
Journal:  J Clin Endocrinol Metab       Date:  1997-06       Impact factor: 5.958

5.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

6.  Prenatal androgenization affects gender-related behavior but not gender identity in 5-12-year-old girls with congenital adrenal hyperplasia.

Authors:  Heino F L Meyer-Bahlburg; Curtis Dolezal; Susan W Baker; Ann D Carlson; Jihad S Obeid; Maria I New
Journal:  Arch Sex Behav       Date:  2004-04

Review 7.  Androgen receptors in prostate cancer.

Authors:  Zoran Culig; Helmut Klocker; Georg Bartsch; Hannes Steiner; Alfred Hobisch
Journal:  J Urol       Date:  2003-10       Impact factor: 7.450

Review 8.  Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia.

Authors:  Gerald Andriole; Nicholas Bruchovsky; Leland W K Chung; Alvin M Matsumoto; Roger Rittmaster; Claus Roehrborn; David Russell; Donald Tindall
Journal:  J Urol       Date:  2004-10       Impact factor: 7.450

9.  The adenovirus-mediated delivery of a reporter gene permits the assessment of androgen receptor function in genital skin fibroblast cultures. Stimulation of Gs and inhibition of G(o).

Authors:  M J McPhaul; J P Deslypere; D R Allman; R D Gerard
Journal:  J Biol Chem       Date:  1993-12-15       Impact factor: 5.157

10.  Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action.

Authors:  Gabriella Castoria; Maria Lombardi; Maria Vittoria Barone; Antonio Bilancio; Marina Di Domenico; Daniela Bottero; Flavia Vitale; Antimo Migliaccio; Ferdinando Auricchio
Journal:  J Cell Biol       Date:  2003-05-12       Impact factor: 10.539

View more
  15 in total

1.  Reconfiguring the AR-TIF2 Protein-Protein Interaction HCS Assay in Prostate Cancer Cells and Characterizing the Hits from a LOPAC Screen.

Authors:  Ashley T Fancher; Yun Hua; Daniel P Camarco; David A Close; Christopher J Strock; Paul A Johnston
Journal:  Assay Drug Dev Technol       Date:  2016-09-08       Impact factor: 1.738

2.  Antioxidant activities of recombinant amphioxus (Branchiostoma belcheri) apolipoprotein D.

Authors:  Yu Zhang; Yi Cong; Shaohui Wang; Shicui Zhang
Journal:  Mol Biol Rep       Date:  2010-09-17       Impact factor: 2.316

3.  Androgen receptor mutations associated with androgen insensitivity syndrome: a high content analysis approach leading to personalized medicine.

Authors:  Adam T Szafran; Sean Hartig; Huiying Sun; Ivan P Uray; Maria Szwarc; Yuqing Shen; Sanjay N Mediwala; Jennifer Bell; Michael J McPhaul; Michael A Mancini; Marco Marcelli
Journal:  PLoS One       Date:  2009-12-09       Impact factor: 3.240

4.  Integrated expression profiling and ChIP-seq analyses of the growth inhibition response program of the androgen receptor.

Authors:  Biaoyang Lin; Jun Wang; Xu Hong; Xiaowei Yan; Daehee Hwang; Ji-Hoon Cho; Danielle Yi; Angelita G Utleg; Xuefeng Fang; Dustin E Schones; Keji Zhao; Gilbert S Omenn; Leroy Hood
Journal:  PLoS One       Date:  2009-08-11       Impact factor: 3.240

5.  Use of phage display to identify novel mineralocorticoid receptor-interacting proteins.

Authors:  Jun Yang; Peter J Fuller; James Morgan; Hirotaka Shibata; Donald P McDonnell; Colin D Clyne; Morag J Young
Journal:  Mol Endocrinol       Date:  2014-07-07

6.  Apolipoprotein D (APOD) is a putative biomarker of androgen receptor function in androgen insensitivity syndrome.

Authors:  Mahesh Appari; Ralf Werner; Lutz Wünsch; Gunnar Cario; Janos Demeter; Olaf Hiort; Felix Riepe; James D Brooks; Paul-Martin Holterhus
Journal:  J Mol Med (Berl)       Date:  2009-03-30       Impact factor: 4.599

Review 7.  The role of estrogen receptor α in the regulation of bone and growth plate cartilage.

Authors:  A E Börjesson; M K Lagerquist; S H Windahl; C Ohlsson
Journal:  Cell Mol Life Sci       Date:  2013-03-21       Impact factor: 9.261

Review 8.  The differential role of androgens in early human sex development.

Authors:  Olaf Hiort
Journal:  BMC Med       Date:  2013-06-24       Impact factor: 8.775

9.  Novel associations in disorders of sex development: findings from the I-DSD Registry.

Authors:  Kathryn Cox; Jillian Bryce; Jipu Jiang; Martina Rodie; Richard Sinnott; Mona Alkhawari; Wiebke Arlt; Laura Audi; Antonio Balsamo; Silvano Bertelloni; Martine Cools; Feyza Darendeliler; Stenvert Drop; Mona Ellaithi; Tulay Guran; Olaf Hiort; Paul-Martin Holterhus; Ieuan Hughes; Nils Krone; Lidka Lisa; Yves Morel; Olle Soder; Peter Wieacker; S Faisal Ahmed
Journal:  J Clin Endocrinol Metab       Date:  2013-12-03       Impact factor: 5.958

10.  The Presence of Clitoromegaly in the Nonclassical Form of 21-Hydroxylase Deficiency Could Be Partially Modulated by the CAG Polymorphic Tract of the Androgen Receptor Gene.

Authors:  Vivian Oliveira Moura-Massari; Flávia Siqueira Cunha; Larissa Garcia Gomes; Diogo Bugano Diniz Gomes; José Antônio Miguel Marcondes; Guiomar Madureira; Berenice Bilharinho de Mendonca; Tânia A Sartori Sanchez Bachega
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.